| You
are here: Home: BCU Surgeons
Vol 2, Issue 2: Bernard
Fisher, MD - Select publications
Select publications
Preoperative (neoadjuvant) systemic therapy
Anderson TJ et al. Effect of neoadjuvant treatment with
anastrozole on tumour histology in postmenopausal women with
large operable breast cancer. Br J Cancer 2002;87(3):334-8.
Abstract
Burstein HJ et al. Preoperative therapy with trastuzumab
and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide
for HER2 overexpressing stage II or III breast cancer: A pilot
study. J Clin Oncol 2003;21(1):46-53. Abstract
Dixon JM et al. Neoadjuvant endocrine therapy of breast
cancer: A surgical perspective. Eur J Cancer 2002;38(17):2214-21.
Abstract
Ellis MJ et al. Letrozole is more effective neoadjuvant
endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive,
estrogen receptor-positive primary breast cancer: Evidence from
a phase III randomized trial. J Clin Oncol 2001;19(18):3808-16.
Abstract
Geisler J et al. Influence of neoadjuvant anastrozole
(Arimidex) on intratumoral estrogen levels and proliferation
markers in patients with locally advanced breast cancer. Clin
Cancer Res 2001;7(5):1230- 6. Abstract
Heys SD et al. Neoadjuvant docetaxel in breast cancer:
3-year survival results from the Aberdeen trial. Clin
Breast Cancer 2002;3 Suppl 2:S69-74. Abstract
Newman LA et al. A prospective trial of preoperative chemotherapy
in resectable breast cancer: Predictors of breast-conservation
therapy feasibility. Ann Surg Oncol 2002;9(3):228-34.
Abstract
NSABP. The effect on primary tumor response of adding
sequential Taxotere to Adriamycin and cyclophosphamide: Preliminary
results from NSABP Protocol B-27. Breast Cancer Res
Treat 2001;Abstract
5.
Paciucci PA et al. Neo-adjuvant therapy with dose-dense
docetaxel plus short-term filgrastim rescue for locally advanced
breast cancer. Anticancer Drugs 2002;13(8):791-5. Abstract
Smith IC et al. Neoadjuvant chemotherapy in breast cancer:
Significantly enhanced response with docetaxel. J Clin
Oncol 2002;20(6):1456-66. Abstract
van der Hage JA et al. Preoperative chemotherapy in primary
operable breast cancer: Results from the European Organization
for Research and Treatment of Cancer trial 10902. J
Clin Oncol 2001;19(22):4224-37. Abstract
von Minckwitz G et al. Dose-dense doxorubicin, docetaxel,
and granulocyte colony-stimulating factor support with or without
tamoxifen as preoperative therapy in patients with operable carcinoma
of the breast: A randomized, controlled, open phase IIb study. J
Clin Oncol 2001;19(15):3506-15. Abstract
Wolmark N et al. Preoperative chemotherapy in patients
with operable breast cancer: Nine-year results from National
Surgical Adjuvant Breast and Bowel Project B-18. J Natl
Cancer Inst Monogr 2001;(30):96-102. Abstract
|
